Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-647,658
Closed -$14.5M 46
2019
Q4
$14.5M Sell
647,658
-321,080
-33% -$7.12M 3.44% 13
2019
Q3
$21.7M Sell
968,738
-18,055
-2% -$425K 5.12% 2
2019
Q2
$21.9M Sell
986,793
-272,527
-22% -$5.84M 5.07% 3
2019
Q1
$26.9M Buy
1,259,320
+12,797
+1% +$284K 4.29% 7
2018
Q4
$27M Sell
1,246,523
-18,375
-1% -$445K 4.58% 3
2018
Q3
$33M Buy
1,264,898
+34,123
+3% +$876K 4.35% 4
2018
Q2
$30.3M Sell
1,230,775
-437,025
-26% -$10.1M 3.82% 9
2018
Q1
$35.8M Buy
1,667,800
+475,075
+40% +$10.2M 4.17% 8
2017
Q4
$24.4M Buy
+1,192,725
New +$22.8M 2.19% 20

Other funds holding SABR

M.D. Sass LLC's SABR Position: Q1 2020 in Review

M.D. Sass LLC sold out of Sabre (SABR) in Q1 2020, closing a stake of 647,658 shares — an estimated $14.5M sold.

M.D. Sass LLC first reported a position in SABR in Q4 2017 and held it in 9 quarters. The position peaked at $35.8M in Q1 2018. 334 funds tracked by Wall St. Rank hold SABR as of Q1 2020.

  • M.D. Sass LLC reported no remaining Sabre position as of Q1 2020 after selling out during the quarter.
  • M.D. Sass LLC sold 647,658 Sabre shares in Q1 2020, an estimated $14.5M.
  • M.D. Sass LLC first reported a position in Sabre in Q4 2017 and held it in 9 quarters.
  • M.D. Sass LLC's Sabre position peaked at $35.8M in Q1 2018.
  • 334 funds tracked by Wall St. Rank held Sabre as of Q1 2020.

Based on M.D. Sass LLC's 13F filing for Q1 2020, filed 6 May 2020.